{
  "ptid_time": "009_S_5224_2013-07-11",
  "img_path": "/data/qiuhui/data/adni/images/009_S_5224/2013-07-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 62,632 mm³, 62.6% above the reference mean. With a Z-score of 1.50 (93.3th percentile), this represents mild enlargement; hippocampal volume measures 5,411 mm³, 28.4% below the reference mean. With a Z-score of -2.77 (0.3th percentile), this represents significant atrophy; whole brain volume measures 998,950 mm³, 7.5% below the reference mean. With a Z-score of -0.97 (16.7th percentile), this represents normal volume ; entorhinal cortex volume measures 1,757 mm³, 57.2% below the reference mean. With a Z-score of -3.88 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 15,615 mm³, 17.1% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; middle temporal gyrus volume measures 16,004 mm³, 25.0% below the reference mean. With a Z-score of -2.25 (1.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 78.0 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Smoking; Major Surgical Procedures. MMSE: 25.0. MoCA: 24.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.13 SUVR (normal ); Amyloid beta: 890.70 pg/mL (normal ); Total tau: 276.10 pg/mL (normal ); Phosphorylated tau: 26.56 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show significant atrophy in the hippocampus, entorhinal cortex, and middle temporal gyrus—key regions affected in Alzheimer's disease—despite normal CSF biomarkers (Aβ, T-tau, P-tau) and PET (AV45). The MMSE (25) and MoCA (24) scores suggest mild cognitive impairment rather than dementia.  \n**Diagnosis:** **MCI** (likely neurodegenerative, possibly non-AD pathology given biomarker discordance).  \n**Confidence:** **Medium** (due to conflicting imaging/biomarker findings).  \n\n*Note: The profound medial temporal atrophy could suggest primary age-related tauopathy (PART) or limbic-predominant neurodegeneration, but clinical correlation is needed.*",
  "timestamp": "2025-07-25T22:28:04.338890"
}